Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Therese M Becker

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|May 7, 2013
Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanomaMatteo S Carlino, Kavitha Gowrishankar, Catherine A B Saunders, et al.
Cell|May 19, 2010
IGFBP7 is not required for B-RAF-induced melanocyte senescenceLyndee L Scurr, Gulietta M Pupo, Therese M Becker, et al.
Pathology|June 25, 2019
Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinomaDaniel Brungs, Alistair Lochhead, Anita Iyer, et al.
Scientific Reports|January 19, 2020
Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancerDaniel Brungs, Elahe Minaei, Ann-Katrin Piper, et al.
Journal of Cancer Research and Clinical Oncology|February 6, 2021
Human TERT promoter mutations as a prognostic biomarker in gliomaBranka Powter, Sarah A Jeffreys, Heena Sareen, et al.
The Journal of Investigative Dermatology|November 30, 2012
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasionSuzanah C Boyd, Branka Mijatov, Gulietta M Pupo, et al.
Cancers|June 19, 2024
Microsatellite Instability Testing and Prognostic Implications in Colorectal CancerVincent Ho, Liping Chung, Kate Wilkinson, et al.
Plos One|October 5, 2023
Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian populationUdit Nindra, Abhijit Pal, Vivienne Lea, et al.
Internal Medicine Journal|September 15, 2023
Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancerUdit Nindra, Abhijit Pal, Victoria Bray, et al.
Translational Lung Cancer Research|May 20, 2021
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinibPei N Ding, Tara L Roberts, Wei Chua, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|May 7, 2013
Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanomaMatteo S Carlino, Kavitha Gowrishankar, Catherine A B Saunders, et al.
Cell|May 19, 2010
IGFBP7 is not required for B-RAF-induced melanocyte senescenceLyndee L Scurr, Gulietta M Pupo, Therese M Becker, et al.
Pathology|June 25, 2019
Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinomaDaniel Brungs, Alistair Lochhead, Anita Iyer, et al.
Scientific Reports|January 19, 2020
Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancerDaniel Brungs, Elahe Minaei, Ann-Katrin Piper, et al.
Journal of Cancer Research and Clinical Oncology|February 6, 2021
Human TERT promoter mutations as a prognostic biomarker in gliomaBranka Powter, Sarah A Jeffreys, Heena Sareen, et al.
The Journal of Investigative Dermatology|November 30, 2012
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasionSuzanah C Boyd, Branka Mijatov, Gulietta M Pupo, et al.
Cancers|June 19, 2024
Microsatellite Instability Testing and Prognostic Implications in Colorectal CancerVincent Ho, Liping Chung, Kate Wilkinson, et al.
Plos One|October 5, 2023
Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian populationUdit Nindra, Abhijit Pal, Vivienne Lea, et al.
Internal Medicine Journal|September 15, 2023
Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancerUdit Nindra, Abhijit Pal, Victoria Bray, et al.
Translational Lung Cancer Research|May 20, 2021
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinibPei N Ding, Tara L Roberts, Wei Chua, et al.
Pageof 7